Ferris Capital LLC acquired a new position in Zoetis Inc (NYSE:ZTS) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 4,939 shares of the company’s stock, valued at approximately $356,000.
Other large investors have also recently made changes to their positions in the company. Harel Insurance Investments & Financial Services Ltd. purchased a new position in Zoetis during the fourth quarter valued at approximately $108,000. Steward Partners Investment Advisory LLC purchased a new position in Zoetis during the third quarter valued at approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its position in Zoetis by 251.9% during the third quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 1,900 shares of the company’s stock valued at $121,000 after acquiring an additional 1,360 shares in the last quarter. Shine Investment Advisory Services Inc. raised its position in Zoetis by 86.5% during the third quarter. Shine Investment Advisory Services Inc. now owns 2,242 shares of the company’s stock valued at $143,000 after acquiring an additional 1,040 shares in the last quarter. Finally, Advisory Services Network LLC raised its position in Zoetis by 42.4% during the fourth quarter. Advisory Services Network LLC now owns 2,423 shares of the company’s stock valued at $175,000 after acquiring an additional 721 shares in the last quarter. Hedge funds and other institutional investors own 92.45% of the company’s stock.
Several brokerages recently weighed in on ZTS. BMO Capital Markets set a $78.00 price target on Zoetis and gave the company a “hold” rating in a research report on Thursday, February 15th. Piper Jaffray Companies set a $88.00 price objective on Zoetis and gave the company a “buy” rating in a research report on Friday, February 16th. Cantor Fitzgerald set a $85.00 price objective on Zoetis and gave the company a “buy” rating in a research report on Tuesday, January 2nd. UBS Group restated a “neutral” rating on shares of Zoetis in a research report on Friday, November 24th. Finally, Stifel Nicolaus restated a “buy” rating and issued a $86.00 price objective (up from $84.00) on shares of Zoetis in a research report on Friday, February 16th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $80.28.
Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Thursday, February 15th. The company reported $0.69 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.66 by $0.03. The firm had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.40 billion. Zoetis had a return on equity of 65.96% and a net margin of 16.28%. The business’s revenue was up 14.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.47 earnings per share. research analysts predict that Zoetis Inc will post 3.04 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 1st. Shareholders of record on Friday, April 20th will be paid a dividend of $0.126 per share. This represents a $0.50 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date of this dividend is Thursday, April 19th. Zoetis’s dividend payout ratio (DPR) is currently 22.94%.
In other Zoetis news, insider Roman Trawicki sold 23,885 shares of the business’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $82.00, for a total transaction of $1,958,570.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Heidi C. Chen sold 37,453 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $81.02, for a total value of $3,034,442.06. The disclosure for this sale can be found here. Insiders have sold 105,569 shares of company stock worth $8,594,429 in the last three months. 0.31% of the stock is currently owned by corporate insiders.
TRADEMARK VIOLATION WARNING: This piece was published by Week Herald and is the sole property of of Week Herald. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://weekherald.com/2018/03/14/ferris-capital-llc-invests-356000-in-zoetis-inc-zts.html.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.